The US Food and Drug Administration (FDA) has approved AbbVie and Neurocrine Biosciences’ drug Orilissa (elagolix) for women with moderate...
Read More...
The post FDA approves AbbVie’s Orilissa for endometriosis pain appeared first on Pharmaceutical Technology.
Original Article: FDA approves AbbVie’s Orilissa for endometriosis pain